Top 50 Dna Data Storage

Biomemory develops DNA Drives that utilize molecular engineering to store data at a density one million times greater than traditional SSDs or magnetic tape. This technology addresses the need for long-term, energy-efficient data storage solutions with minimal environmental impact, ensuring data durability for thousands of years.

This startup develops an end-to-end integrated microfluidics chip that uses CRISPR-based DNA editing to write, read, and store digital data in bacterial DNA. This technology offers researchers a novel method for high-density, long-term data storage and retrieval.

Cache DNA is developing a wet operating system for the storage and retrieval of biomolecules, utilizing scalable nucleic acid storage techniques to preserve biological data indefinitely. This technology addresses the challenge of data loss by enabling the long-term retention of both digital and biological information without the need for deletion.

The startup has developed a genome-analysis platform that facilitates the acquisition, analysis, and storage of genomic data without the need for repeated sequencing of the same genome for different tests. This technology enables healthcare providers to efficiently manage genetic data and deliver precise DNA sequencing services, enhancing the overall effectiveness of genomic research and patient care.

This startup offers whole genome sequencing technology that analyzes 100% of an individual's DNA, providing detailed insights into health risks, medication responses, and nutritional needs. By delivering personalized reports based on genetic data, the company empowers users to make informed health decisions and improve their overall well-being.

This startup offers next-day plasmid sequencing services with integrated bioinformatics analysis. Their platform provides high-throughput, quality, and cost-effective sequencing, supporting bioscience research globally.

Switchback Systems has developed a scalable benchtop DNA synthesis platform that integrates oligonucleotide synthesis and gene assembly capabilities, significantly reducing the time, cost, and waste associated with traditional DNA synthesis methods. This technology empowers scientists across various industries, including pharmaceuticals and agriculture, to efficiently produce custom DNA sequences for research and development.

Tailwind Biotech provides artificial DNA design services using proprietary artificial intelligence to optimize DNA sequences for bioproduction companies. This technology enhances gene expression and reduces development costs, enabling more efficient and effective genetic engineering processes.

Ansa Biotechnologies utilizes proprietary enzymatic technology to synthesize complex DNA sequences up to 5 kb in length without the need for assembly, enabling the direct synthesis of challenging constructs such as GC-rich sequences and CRISPR arrays. This technology addresses the limitations of traditional DNA synthesis methods, allowing researchers to obtain reliable and rapid access to the complex sequences necessary for advanced scientific projects.

Nebula Genomics offers Whole Genome Sequencing that decodes 100% of an individual's DNA, providing comprehensive insights into health risks, ancestry, and genetic traits. Utilizing blockchain technology, the platform ensures users maintain full ownership and privacy of their genomic data while receiving regular updates based on the latest scientific research.

BioCompute Inc is developing a sustainable data storage solution that significantly reduces carbon emissions associated with traditional data centers. By utilizing alternative storage technologies, the company addresses the environmental impact of data management in a rapidly growing digital landscape.

Elegen utilizes proprietary cell-free DNA synthesis technology to produce long, complex, linear DNA up to 7 kb with 99.999% accuracy, eliminating the need for cloning. This rapid synthesis, delivered in 6 to 8 business days, addresses the critical bottleneck in DNA supply for synthetic biology applications, significantly reducing project timelines and costs.

Twist Bioscience offers a semiconductor-based DNA synthesis platform for high-throughput, cost-effective production of custom DNA. Their technology enables rapid generation of genes, oligo pools, and variant libraries, accelerating research in synthetic biology, drug discovery, and diagnostics.

This company provides a software platform that integrates multi-omics data with domain expertise and knowledge, transforming scientific and technological information into actionable insights. Their solution accelerates research and development in the healthcare and life science industries by making complex data more accessible and useful.

The startup has developed a gene-editing technology that enables scalable digital genome engineering through a user-friendly interface. This technology produces low-cost libraries of thousands of designer protein and genome variants, each with specific and trackable mutations, facilitating efficient research and development in genetic engineering.

The startup operates a personal health and genomic data-sharing platform that connects users with researchers, enabling participation in studies on common and rare diseases. By allowing individuals to control their data and opt into research, the platform facilitates the collection of dynamic health and genetic datasets for personalized medicine.

Galatea Bio utilizes next-generation sequencing and a large-scale genomic-phenotypic data lake to facilitate precision health initiatives for diverse populations. The company addresses the need for comprehensive genetic testing and biobanking solutions that respect participant privacy while enabling advanced biomedical research.

Enigma Genomics utilizes next-generation sequencing technologies and artificial intelligence to decode individual genomes, providing personalized genetic insights that inform health decisions. The platform enables users to access and control their genetic data for life, facilitating proactive disease prevention and tailored medical treatments.

Camena Bioscience develops the gSynth® platform, a TdT-free enzymatic DNA synthesis technology that enables the high-throughput production of synthetic genes of any sequence, length, and complexity. This technology addresses the limitations of traditional DNA synthesis methods, which struggle to produce long, accurate synthetic DNA at scale, thereby facilitating advancements in personalized mRNA vaccines, cell and gene therapies, and CRISPR applications.

Kano Therapeutics develops circular single-stranded DNA (ssDNA) templates using a fermentation-based production method to enable precise gene-length DNA insertion with higher efficiency and lower off-target effects. This technology addresses the limitations of existing gene editing tools by providing a safe and effective means for genomic engineering, facilitating the transition from gene editing to complete genetic cures.

The startup develops a data conversion and storage platform that encodes digital information into deoxyribonucleic acid (DNA) format, providing a long-term archival solution. This technology enables customers to economically store vast amounts of data in DNA molecules, addressing the limitations of traditional digital storage methods.

Igentify Ltd offers a digital platform that streamlines genomic workflows, enabling patients, laboratories, and healthcare providers to access and interpret genetic information securely. This solution addresses the challenge of inefficient genetic data management, enhancing the effectiveness of preventive healthcare services.

This startup develops DNA technology tailored for synthetic biology applications, providing high-throughput libraries and custom DNA sequences for genome construction and data storage. Their services enable researchers and companies to efficiently create and manipulate DNA without facing economic or time constraints.

GitLife Biotech provides a version control system for synthetic biology through its CellRepo™ platform, which organizes and secures data generated during strain engineering processes. This technology enhances traceability and ownership of biological assets by linking digital records to unique DNA Genosignatures®, ensuring precise documentation and compliance in genetic engineering.

The startup develops a genotyping and sequencing platform that translates genetic data into clinical applications, enabling healthcare providers to make informed treatment decisions. This technology enhances patient care and biomedical research by improving the understanding and management of diseases.

The startup provides permanent blockchain storage that utilizes end-to-end encryption to secure files and messages on-chain, ensuring user privacy and data ownership. This solution enables individuals and web3 startups to store and collaborate on sensitive information in a decentralized manner, protecting against data exploitation.

Genomes.io provides a secure platform for individuals to upload their genomic data and retain ownership while enabling pharmaceutical and research organizations to access this data for studies through a blockchain-based consent system. This approach addresses the lack of transparency and equitable compensation in the genomics market, allowing users to monetize their DNA data while maintaining privacy and control.

Kern Systems develops a DNA data storage platform that utilizes synthetic DNA molecules and enzymes to create a scalable, cold storage solution for unstructured data. This technology addresses the growing demand for data storage by offering a medium that is denser, more durable, and energy-efficient compared to traditional storage methods.

Ribbon Biolabs utilizes algorithm-driven technology to synthesize pristine synthetic DNA molecules, producing linear DNA up to 12 kb and plasmids up to 20 kb with high accuracy and complexity. This addresses the critical demand for longer and more complex synthetic DNA that existing technologies fail to deliver, enabling advancements in various sectors of synthetic biology.

GoodCell is a biotechnology company specializing in the personal biobanking of stem cells, plasma, and DNA, along with diagnostic genetic screening. This service provides individuals with secure storage of their biological materials for potential future medical use, addressing the need for personalized health management and regenerative therapies.

This microbiome-based life sciences company develops healthcare solutions using big data analytics, mathematical modeling, deep learning, and AI. Their technology analyzes the human microbiome to provide insights that support individual health and well-being.

HoloMem develops a cold data storage technology that uses holograms to store data at ultra-high density with zero energy consumption. Their solution offers a plug-and-play cartridge that can hold up to 200TB, providing a considerably cheaper and infinitely readable alternative for data managers.

ClutchBio provides modular DNA toolkits and plasmid design software that streamline the cloning process, significantly reducing turnaround times for sequence-verified plasmid DNA. By eliminating cloning as a bottleneck, ClutchBio enhances research productivity and enables faster experimental iteration for biological researchers.

The startup specializes in DNA sequencing technologies, offering short-read sequencers that deliver ultra-long-range results for diploid genomes of various sizes. This capability enables precise applications such as de novo sequencing and structural variation detection, allowing businesses to efficiently generate customizable sequencing libraries tailored to their specific genomic needs.

DNAstack offers Omics AI, a software suite that enables the secure connection, protection, and analysis of federated omics and health data using AI-powered tools compliant with Global Alliance for Genomics & Health standards. This platform addresses the challenge of accessing and analyzing large, sensitive datasets without the need to move them, facilitating collaborative research across distributed networks.

Inso Biosciences develops microfluidic hardware platforms for high-efficiency genomic sample handling, focusing on long-read DNA extraction and multiomic sample processing. Their technology addresses the challenges of cellular material processing and pathogen surveillance, enhancing accuracy and speed in genomic research.

Genomelink allows users to upload raw DNA data from services like AncestryDNA, 23andMe, or MyHeritage for enhanced genetic analysis, providing insights into ancestry, health, and personal traits. This platform addresses the lack of detailed genetic information by offering over 350 unique traits and specialized reports that are not available through standard DNA testing services.

DINYA DNA specializes in rapid, cost-effective de novo synthesis of gene-length DNA sequences, utilizing proprietary synthetic biology processes. This technology enables researchers to create custom DNA sequences efficiently, accelerating their research and development timelines.

This startup provides an AI-powered blockchain platform for decentralized science, specifically focused on genomics. It offers researchers access to clean, labeled, and organized genetic profiles, accelerating the development of personalized, data-driven medical solutions and reducing time-to-market for genomics-based AI applications.

PandMe offers DNA testing and analysis services, providing users with insights into their ancestry, family history, and genetic predispositions. The company also provides researchers with categorized and searchable genomic data to accelerate scientific discovery.

The startup operates a genomics platform that centralizes and integrates DNA data to provide precise diagnoses and personalized treatment plans through advanced data analysis and interpretation. By leveraging genomic information, the platform enables researchers to enhance health outcomes and preventive care strategies for individuals.

intoDNA provides an end-to-end service for DNA break detection using its proprietary STRIDE™ technology, which quantitatively measures free DNA ends and identifies specific types of DNA damage in various biological materials. This technology enables precision biomarker discovery, facilitating informed decision-making in targeted therapeutics development and patient selection.

XGenomes develops DNA sequencing technologies that utilize optical super-resolution imaging and machine learning to monitor health, detect early disease signals, and track interventions throughout an individual's life. Their platform addresses high error rates and complex workflows in existing sequencing methods, providing a streamlined and cost-effective solution for continuous health monitoring.

BacStitch DNA is developing an in vivo DNA engineering platform that simplifies the assembly of long and complex DNA sequences, enabling high-fidelity constructions ranging from under 10kb to over 50kb. This platform reduces reliance on traditional in vitro methods, allowing for cost-effective and efficient creation of genetic constructs, including those with challenging features like high GC content and repetitive sequences.

Sophgena provides genetic analysis and DNA testing services, utilizing liquid biopsies and long-read sequencing to deliver personalized medical insights. The company enables individuals to understand their genetic predispositions, facilitating early detection and tailored treatment options for congenital and acquired diseases.

As the company is operating in stealth mode and no homepage content is available, a description cannot be provided.

The startup offers a blockchain technology platform that enables decentralized applications to utilize multi-chain data co-storage and cross-chain data management with a focus on data privacy protection. This platform addresses the limitations of traditional storage services by providing unlimited scalability and secure data storage solutions for users.

This startup provides an AI-powered platform that analyzes an individual's DNA to offer personalized recommendations for diet, fitness, and supplements. It aims to make genetic-based healthy lifestyle planning accessible and affordable for consumers.

This company analyzes individual genetic data to provide personalized health recommendations and treatment plans. By leveraging insights from a person's unique genetic makeup, they aim to optimize healthcare decisions for improved outcomes.

PetaGene provides a lossless compression solution for genomic data, utilizing multi-threaded software to reduce file sizes by 60% to 90% without compromising data integrity. This technology addresses the high costs and lengthy transfer times associated with storing and managing large genomic datasets, enabling more efficient data handling in research and clinical settings.